nach oben

Erschienen in:

01.12.2010 | Original Article

Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance

verfasst von: Ali Bidari, Banafsheh Ghavidel-Parsa, Hossein Najmabadi, Elham Talachian, Majid Haghighat-Shoar, Behrooz Broumand, Babak Ghalehbaghi

Erschienen in: Modern Rheumatology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of our study was to determine the spectrum of the 12 most common familial Mediterranean fever gene (MEFV) mutations in Iranian patients with heterogeneous ethnicity, using the familial Mediterranean fever (FMF) strip assay test. A total of 36 patients were diagnosed according to established clinical criteria. Genomic DNA from all patients was tested for 12 common mutations located in exon 2 (E148Q), 3 (P369S), 5 (F479L), 10 [M680I (G>C), M680I (G>A), I692del, M694V, M694I, K695R, V726A, A744S, R761H], respectively, using the FMF strip assay test. Of the 35 patients with mutations, ten were homozygote, 20 were compound heterozygote, and five were heterozygote. The most frequent genotype was M680I/M680I (6 patients, 16.7%). The most frequent mutation was M680I, followed by M694V, and V726A. The FMF strip assay test for common these 12 mutations was positive in 90.6% of alleles in this study, indicating that it appears to be an effective method for FMF mutation screening in Iranian patients.

Onen F. Familial Mediterranean fever. Rheumatol Int. 2005;26:489–96.PubMedCrossRef

El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet. 2006;367:1016–24.PubMedCrossRef

Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.PubMedCrossRef

The international FMF consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807.CrossRef

INFEVERS. The registry of familial Mediterranean fever (FMF) and hereditary autoinflammatory disorders mutations. Available at: http://fmf.igh.cnrs.fr/ISSAID/infevers. Accessed 19 Feb 2010.

Touitou I. Standardized testing for mutations in familial Mediterranean fever. Clin Chem. 2003;49:1781–2.PubMedCrossRef

Oberkanins C, Weinhausel A, Kriegshauser G, Moritz A, Kury F, Haas OA. Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips. Clin Chem. 2003;49:1948–50.PubMedCrossRef

Tchernitchko D, Legendre M, Delahaye A, Cazeneuve C, Niel F, Goossens M, et al. Clinical evaluation of reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. Clin Chem. 2003;49:1942–5.PubMedCrossRef

Esmaeili M, Bonyadi M, Rafeey M, Sakha K, Somi M. Common MEFV mutation analysis in Iranian Azeri Turkish patients with familial Mediterranean fever. Semin Arthritis. 2008;37:334–8.

10.

Najmabadi H, Neishabury M, Sahebjam F, Kahrizi K, Shafaghati Y, Nikzat N, et al. The Iranian Human Mutation Gene Bank: a data and sample resource for worldwide collaborative genetics research. Hum Mutat. 2003;21:146–50.PubMedCrossRef

11.

Saadat M, Ansari-Lari M, Farhud D. Consanguineous marriage in Iran. Ann Hum Biol. 2004;31:263–9.PubMedCrossRef

12.

Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.PubMedCrossRef

13.

Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, et al. Clinical difference between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216–9.PubMedCrossRef

14.

Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum. 2005;35:57–64.PubMedCrossRef

15.

Miller SA, Dynes DD, Polesky F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.PubMedCrossRef

16.

Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009;36:1671–6.PubMedCrossRef

17.

Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. FMF in Turkey: result of a nationwide multicenter study. Medicine (Balitmore). 2005;84:1–11.CrossRef

18.

Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.PubMedCrossRef

19.

Akar N, Misiroglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N, et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat. 2000;15:118–9.PubMedCrossRef

20.

Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9:553–5.PubMedCrossRef

21.

Ben-Chetrit E, Urieli-Shoval S, Calko S, Abeliovich D, Matzner Y. Molecular diagnosis of FMF: lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol. 2002;20:S25–9.PubMed

22.

Majeed HA, El-Khateeb M, El-Shanti H, Abu Rabaiha Z, Tayeh M, Najib D. The spectrum of familial Mediterranean fever gene mutations in Arabs: report of a large series. Semin Arthritis Rheum. 2005;34:813–8.PubMedCrossRef

23.

Sarkisian T, Ajrapetyan H, Shahsuvaryan G. Molecular study of FMF patients in Armenia. Curr Drug Targets Inflam Allergy. 2005;4:113–6.CrossRef

24.

Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavourable renal prognosis of the M694V homozygous genotype—genetic and therapeutic implications. Am J Hum Gene. 1999;65:88–97.CrossRef

25.

Dode C, Pecheux C, Cazeneuve C, Cattan D, Dervichian M, Goossens M, et al. Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever. Am J Med Genet. 2000;92:241–6.PubMedCrossRef

26.

Medlej-Hashim M, Rawashdeh M, Chouery E, Mansour I, Delague V, Lefranc G, et al. Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients. Hum Mutat. 2000;15:384.PubMedCrossRef

27.

Al-Alami JR, Tayeh MK, Najib DA, Abu-Rubaiha ZA, Majeed HA, Al-Khateeb MS, et al. Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population. Saudi Med J. 2003;24:1055–9.PubMed

28.

Mattit H, Joma M, Al-Cheikh S, El-Khateeb M, Medlej-Hashim M, Salem N, et al. Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype–genotype correlation. Eur J Med Genet. 2006;49:481–6.PubMedCrossRef

29.

Ertekin V, Selimoglu MA, Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey. Pediatr Int. 2005;47:640–4.PubMedCrossRef

30.

Papadopoulos VP, Giaglis S, Mitroulis I, Ritis K. The population genetics of familial mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72:752–61.PubMedCrossRef

31.

Sugiura T, Kawaguchi Y, Fujikawa S, Hirano Y, Igarashi T, Kawamoto M, et al. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol. 2008;18:57–9.PubMedCrossRef

32.

Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, et al. MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol. 2008;26:13–7.PubMed

33.

Akarsu AN, Saatci U, Ozen S, Bakkaloglu A, Besbas N, Sarfarazi M. Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population. J Med Genet. 1997;34:573–8.PubMedCrossRef

34.

Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet. 2000;67:1136–43.PubMed

35.

Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum. 2001;44:163–9.PubMedCrossRef

36.

Caglayan AO, Demiryilmaz F, Ozyazgan I, Gumus H. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study. Nephrol Dial Transpl. 2009;23:1–4.

37.

Delague V, Kriegshäuser G, Oberkanins C, Mégarbané A. Reverse-hybridization vs. DNA sequencing in the molecular diagnosis of familial Mediterranean fever. Genetic Testing. 2004;8(1):65–8.

38.

Akin H, Onay H, Turker E, Cogulu O, Ozkinay F. MEFV mutations in patients with familial Mediterranean fever from the Aegean region of Turkey. Mol Biol Rep. 2010;37(1):93–8.PubMedCrossRef

39.

Gunel-Ozcan A, Sayin DB, Misirlioğlu ED, Güliter S, Yakaryilmaz F, Ensari C. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kirikkale University in Turkey. Mol Biol Rep. 2009;36:757–60.PubMedCrossRef

Titel: Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance
verfasst von: Ali Bidari
Banafsheh Ghavidel-Parsa
Hossein Najmabadi
Elham Talachian
Majid Haghighat-Shoar
Behrooz Broumand
Babak Ghalehbaghi
Publikationsdatum: 01.12.2010
Verlag: Springer Japan
Erschienen in: Modern Rheumatology / Ausgabe 6/2010
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI: https://doi.org/10.1007/s10165-010-0317-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α

Etanercept response in patients with rheumatoid arthritis after secondary loss of efficacy of infliximab

Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis

Acupuncture needle-associated prosthetic knee infection after total knee arthroplasty

Erratum to: Aspects of TNF inhibitor therapy in rheumatoid arthritis

An attack of acute neuro-Behçet’s disease during the course of chronic progressive neuro-Behçet’s disease: report of two cases

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin